Paraspinal and scapular myopathy associated with scleroderma

Journal of Clinical Neuromuscular Disease

Volumn 11, Issue 4, 2010, Pages 213-222

  Rojana Udomsart, Arada ^a,c   Fabian, Vicki ^b   Hollingsworth, Peter N ^b   Walters, Susan E ^a   Zilko, Paul J ^a   Mastaglia, Frank L ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c Yala Hospital   (Thailand)

Author keywords

Bent spine; Dropped head; Paraspinal and scapular myopathy; Scleroderma

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CELL NUCLEUS ANTIGEN; CREATINE KINASE; CYCLOSPORIN; IMMUNOGLOBULIN; METHOTREXATE; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DELTOID MUSCLE; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROMYOGRAPHY; FEMALE; HUMAN; LABORATORY TEST; LOW DRUG DOSE; MALE; MEDICAL RECORD REVIEW; MOTOR UNIT POTENTIAL; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; MYOSITIS; NECK MUSCLE; NEUROLOGIC EXAMINATION; PARASPINAL MYOPATHY; PRIORITY JOURNAL; SCAPULAR MYOPATHY; SCLERODERMA; SHOULDER GIRDLE; TREATMENT OUTCOME;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD; ELECTROMYOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; RHEUMATOID FACTOR; SCAPULA; SCLERODERMA, LOCALIZED; SPINAL CURVATURES;

EID: 77953256225     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e3181c139f6     Document Type: Article

References (38)

1. Black CM. Scleroderma-clinical aspects. J Intern Med. 1993;2:115-118.
2. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;2:202-205.
3. Ringel RA, Brick JE, Brick JF, et al. Muscle involvement in the scleroderma syndromes. Arch Intern Med. 1990;12:2550-2552.
4. Averbuch-Heller L, Steiner I, Abramsky O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol. 1992;12:1292-1295.
5. Hietaharju A, Jaaskelainen S, Kalimo H, et al. Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma). Muscle Nerve. 1993;11: 1204-1212.
6. Follansbee WP, Zerbe TR, Medsger TA Jr. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J. 1993;1: 194-203.
7. Zilko PJ. Myopathy in connective tissue disease other than polymyositis. In: "Inflammatory Diseases of Muscle". Oxford: Blackwell Scientific Publications; 1998; pp. 107-124.
8. Mimura Y, Ihn H, Jinnin M, et al. Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol. 2005;2:99-102.
9. Medsger TA Jr, Rodnan GP, Moossy J, et al. Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum. 1968;4:554-568.
10. Clements PJ, Furst DE, Campion DS, et al. Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum. 1978;1:62-71.
11. Olsen NJ, King LE Jr, Park JH. Muscle abnormalities in scleroderma. Rheum Dis Clin North Am. 1996;4: 783-796.
12. Greenberg SA, Amato AA. Inflammatory myopathy associated with mixed connective tissue disease and scleroderma renal crisis. Muscle Nerve. 2001;11: 1562-1566.
13. Mastaglia FL. Inflammatory Diseases of Muscle. Oxford: Blackwell Scientific Publications; 1988.
14. Hausmanowa-Petrusewicz I, Blaszczyk M, Kowalska-Oledzka E, et al. Scleromyositis a distinctive overlap syndrome. Acta Myologica. 2000;19:201-204.
15. Tome FM, Fardeau M, Lebon P, et al. Inclusion body myositis. Acta Neuropathol Suppl. 1981:287-291.
16. Somer H, Haltia M, Somer T, et al.Inclusion body myositis in scleroderma: improvement with steroids. Muscle Nerve. 1986;9:220.
17. Dunne JW, Heye N, Edis RH, et al. Necrotizing inflammatory myopathy associated with localized scleroderma. Muscle Nerve. 1996;8:1040-1042.
18. Bockle BC, Willeit J, Freund M, et al. Neurological picture. Unexplained muscle atrophy as the unique preceding symptom of bilateral linear morphea. J Neurol Neurosurg Psychiatry. 2009;3:310-311.
19. Needham M, Mastaglia FL. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol. 2007;7: 620-631.
20. Biran I, Cohen O, Diment J, et al. Focal, steroid responsive myositis causing dropped head syndrome. Muscle Nerve. 1999;6:769-771.
21. Hund E, Heckl R, Goebel HH, et al. Inclusion body myositis presenting with isolated erector spinae paresis. Neurology. 1995;5:993-994.
22. Rose MR, Levin KH, Griggs RC. The dropped head plus syndrome: quantitation of response to corticosteroids. Muscle Nerve. 1999;1:115-118.
23. Slobodin G, Rozenbaum M, Weller B, et al. Dropped head: an unusual presentation of dermatomyositis. J Rheumatol. 2005;6:1174-1175.
24. Kastrup A, Gdynia HJ, Nagele T, et al. Dropped-head syndrome due to steroid responsive focal myositis: a case report and review of the literature. J Neurol Sci. 2008;1-2:162-165.
25. Gono T, Katsumata Y, Kawaguchi Y, et al. Selective expression of MHC class I in the affected muscle of a patient with idiopathic inflammatory myopathy. Clin Rheumatol. 2009;7:873-876.
26. Rosato E, Rossi C, Salsano F. Dropped head syndrome and systemic sclerosis. Joint Bone Spine. 2009;3:301-303.
27. Lange D, Fetell M, Lovelace R, et al. The floppy head syndrome. Ann Neurol. 1986;1:133.
28. Oerlemans WG, de Visser M. Dropped head syndrome and bent spine syndrome: two separate clinical entities or different manifestations of axial myopathy? J Neurol Neurosurg Psychiatry. 1998;2: 258-259.
29. Katz JS, Wolfe GI, Burns DK, et al. Isolated neck extensor myopathy: a common cause of dropped head syndrome. Neurology. 1996;4:917-921.
30. Suarez GA, Kelly JJ Jr. The dropped head syndrome. Neurology. 1992;8:1625-1627.
31. Genge A, Arnold D, Shubridge E, et al. Head drop myopathy. Neuromuscular Disorders. 1996;7:60.
32. Goh KJ, Wong KT, Tan CT. Myopathic dropped head syndrome: a syndrome of mixed aetiology. J Clin Neurosci. 2000;4:334-336.
33. Pestronk A, Kos K, Lopate G, et al. Brachio-cervical inflammatory myopathies: clinical, immune, and myopathologic features. Arthritis Rheum. 2006;5: 1687-1696.
34. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol. 1984;2:193-208.
35. Derk CT, Jimenez SA. Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev. 2003;4:181-191.
36. Zuber JP, Spertini F. Immunological basis of systemic sclerosis. Rheumatology (Oxford). 2006:iii23-iii25.
37. Sakkas LI, Xu B, Artlett CM, et al. Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol. 2002;7:3649-3659.
38. Dominick J, Sheean G, Schleimer J, et al. Response of the dropped head/bent spine syndrome to treatment with intravenous immunoglobulin. Muscle Nerve. 2006;6:824-826.